Edition:
United Kingdom

People: Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

12.99USD
16 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$12.99
Open
$12.77
Day's High
$13.06
Day's Low
$12.64
Volume
159,476
Avg. Vol
240,753
52-wk High
$19.48
52-wk Low
$9.14

Swisher, Daniel 

Mr. Daniel N. Swisher Jr., is an Independent Director of Corcept Therapeutics Incorporated. He became a member of our Board in June 2015. He has been the President and Chief Operating Officer of Jazz Pharmaceuticals since January 2018. From 2003 to December 2017, he was Chief Executive Officer and a member of the board of directors of Sunesis Pharmaceuticals, a clinical-stage biopharmaceutical company. From 2005 to 2017, he was also its President. He joined Sunesis in 2001 and had previously served as the company’s chief business officer and chief financial officer. Prior to that, Mr. Swisher held a range of senior management roles, including Senior Vice president of Sales and Marketing at ALZA Corporation, a pharmaceutical and medical systems company, from 1992 to 2001. Mr. Swisher has served as Chairman of the Board of Cerus Corporation, a publicly traded biopharmaceutical company, since 2013. Mr. Swisher received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Swisher brings to our Board experience in life science industry sales, operations and finance.

Basic Compensation

Total Annual Compensation, USD 67,375
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 212,889
Fiscal Year Total, USD 280,264

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Wilson

758,669

Joseph Belanoff

6,314,620

Gary Robb

2,845,670

Sean Maduck

2,806,070

Andreas Grauer

--

George Baker

267,889
As Of  31 Dec 2018